Persistence Market Research

Wound Cleanser Products Market to Register Steadfast CAGR of 3.2% in Terms of Value over Forecast Period, 2017-2025

Persistence Market Research has announced the addition of the “Global Market Study on Wound Cleanser Products: Antiseptics Product Type Segment Expected to be the Second Largest in Terms of Market Value by 2025 End" report to their offering.


New York, NY -- (SBWIRE) -- 10/01/2018 -- Persistence Market Research has analyzed various facets of the wound cleanser products market from a global standpoint and has skilfully presented these in its new research publication titled "Wound Cleanser Products Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)". This report covers various trends, opportunities, drivers and restraints influencing the growth of the global wound cleanser products market along with regional analysis, competitive scenario and revenue forecasts. This analysis focuses on each segment and sub-segment of the global market based on which the analysts have given their insights regarding various market dynamics.

Global Wound Cleanser Products Market: Forecast Insights

The global wound cleanser products market is expected to grow at a sluggish CAGR of 3.2% during the forecast period. The global wound cleanser products market is anticipated to reach a valuation of about US$ 1.9 Bn by the end of the assessment year in 2025, up from an estimated US$ 1.5 Bn in 2017.

Global Wound Cleanser Products Market: Segmental Insights

The global wound cleanser products market is segmented by product type, by form type, by end user, by wound type and by region.By form type, gels segment is expected to outpace other segments and reflect a CAGR of 4.3% during the forecast period. Solutions segment in this category is the largest in terms of value.

By wound type, chronic wounds segment reflects high potential for growth and is projected to expand at a CAGR of 5.2% during the period of assessment.By end user, hospitals is the largest and most lucrative end user segment and is anticipated to reflect a valuation of around US$ 700 Mn by the end of the assessment year, thus leading the global market.By product type, wetting agents segment is expected to hold a high market share and reach a valuation of more than US$ 740 Mn by the end of the year of assessment.By region, Asia Pacific is poised to be the second largest, reflecting very high potential with respect to growth. The wound cleanser products market in this region is poised to register a CAGR of 4.5%.

Request for Sample Report @

Global Wound Cleanser Products Market: Dynamics Influencing Growth

Rising prevalence of chronic wounds, favorable reimbursement ratio, expansion of product line, rising adoption of advanced wound care products, increasing demand for advanced wound care products in home care settings, rising prevalence of diabetes, increasing focus of healthcare facilities on educational programs, a growing awareness among patients, high availability of wound and burn care products in the market, growing acceptance of standardized protocols to manage complex wounds, expansion in emerging economies, collaborative agreements among manufacturers and distributors, high focus on acquisitions to strengthen the product portfolio and increasing preference for accelerated wound healing are pushing the growth of the global wound cleanser products market. However, aspects such as high demand for low frequency dressing change in acute care settings, lack of skilled labor, and high cost of advanced wound care dressings is hindering the growth of the global wound cleanser products market.

The research report on the global wound cleanser products market features a detailed research analysis on competition that includes various key players in the market. Details such as SWOT analysis, company overview, developments, product portfolio, strategies and financials of major companies such as Smith & Nephew Plc., Reckitt Benckiser Group Plc., B. Braun Melsungen AG, Convatec Group Plc., Johnson & Johnson Services Inc., C. R. Bard, Inc., Coloplast Group, 3M, Molnlycke Healthcare, Medtronic Plc., and Derma Sciences Inc., are covered in this research report.

Request for Table of Content (ToC):